Projects per year
Personal profile
About
Manmeet Ahluwalia, M.D., FACP, M.B.A., is the chief of solid tumor medical oncology, deputy director and chief scientific officer at Miami Cancer Institute. As a neuro-oncologist, Dr. Ahluwalia’s primary areas of research and patient care are primary tumors and brain metastases. He joined Miami Cancer Institute from the Cleveland Clinic, where he was the Dean and Diane Miller Family Endowed Chair in Neuro-Oncology and the Head of Operations in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center (BBTC). He also served as a professor in the Department of Medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.
Dr. Ahluwalia helped develop a world-class clinical trials program for brain tumors at the Cleveland Clinic. These trials involved immunotherapy and precision medicine-based approaches to target genetic alterations that drive disease. His research has been published in over 175 peer-reviewed publications, including the JAMA, JAMA Oncology, Neuro-Oncology, Journal of Clinical Oncology, Clinical Cancer Research, Cancer Discovery, Nature Reviews Neurology, Nature Reviews and Nature Reviews Clinical Oncology. In 2016, he was selected to participate in the American Society of Clinical Oncology’s Leadership Development Program. This prestigious year-long program allowed Dr. Ahluwalia to work with the top leaders in oncology from all over the world. He and his colleagues designed research for patients, caregivers and other oncologists to help them advance the field of oncology. As part of this program, he also met with members of Congress on Capitol Hill to promote funding for cancer research.
Dr. Ahluwalia is fluent in English, Hindi and Punjabi. In addition to his medical degree, Dr. Ahluwalia holds a Master of Business Administration from Case Western Reserve and the Cleveland Clinic.
Related documents
Education/Academic qualification
M.B.A., Business Administration (Healthcare track), Case Western Reserve University
2018 → 2020
Fellowship Program - Hematology Oncology, Roswell Park Center Institute
2006 → 2009
Cleveland Clinic Health System, Residency Program - Internal Medicine, Fairview Hospital
2003 → 2006
Department of Pathobiology & Laboratory Medicine, Research Fellowship, University of Toronto
2002 → 2003
Maulana Azad Medical College, Medicine & Surgery, M.B.B.S., University of Delhi
1995 → 2000
Senior, Secondary Examination, Delhi Public School
1993 → 1995
External positions
Program Director, Neuro-Oncology Fellowship, Cleveland Clinic , Cleveland, Ohio
Jan 1 2017 → Jan 1 2020
Head of Operations, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic , Cleveland, Ohio
Jan 1 2015 → Jan 1 2020
Director, brain metastasis research program, brain tumor and neuro-oncology center, Cleveland Clinic, Cleveland, Ohio
Jan 1 2014 → Jan 1 2020
Associate Director Clinical Trials, Operations, brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio
Jan 1 2013 → Jan 1 2020
Section Head , Neuro-Oncology Outcomes, Brain Tumors and Neuro-Oncology Center, Cleveland Clinic , Cleveland, Ohio
Jan 1 2009 → Jan 1 2020
Disciplines
- Medicine and Health Sciences
- Neurology
- Oncology
Projects
- 20 Finished
-
-
RadxTools for assessing tumor treatment response on imaging
Ahluwalia, M. (PI)
National Institute of Health (NIH)
1/1/20 → 1/1/23
Project: Research project
-
Phase 2 Trial of BXQ 350 in Recurrent Glioblastoma
Ahluwalia, M. (PI)
1/1/20 → 1/1/21
Project: Research project
-
Brain tumor research and therapeutic development
Ahluwalia, M. (PI)
1/1/19 → 1/1/22
Project: Research project
-
Phase II study of Pembrolizumab Plus Survaxm for glioblastoma at first recurrence
Ahluwalia, M. (PI)
1/1/19 → 1/1/22
Project: Research project
-
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial Design
Kotecha, R., Akdemir, E. Y., Kutuk, T., Ilgin, C., Ahluwalia, M. S., Bi, W. L., Blakeley, J., Dixit, K. S., Dunn, I. F., Galanis, E., Galldiks, N., Huang, R. Y., Johnson, D. R., Kaley, T. J., Kamson, D. O., Kurz, S. C., McDermott, M. W., Odia, Y., Preusser, M. & Raizer, J. & 8 others, , Jan 14 2025, (E-pub ahead of print) In: Neuro-Oncology.Research output: Contribution to journal › Article › peer-review
-
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions
Badani, A., Ozair, A., Khasraw, M., Woodworth, G. F., Tiwari, P., Ahluwalia, M. S. & Mansouri, A., Feb 2025, In: Journal of Neuro-Oncology. 171, 3, p. 531-547 17 p.Research output: Contribution to journal › Review article › peer-review
-
Leptomeningeal metastatic disease: new frontiers and future directions
Ozair, A., Wilding, H., Bhanja, D., Mikolajewicz, N., Glantz, M., Grossman, S. A., Sahgal, A., Le Rhun, E., Weller, M., Weiss, T., Batchelor, T. T., Wen, P. Y., Haas-Kogan, D. A., Khasraw, M., Rudà, R., Soffietti, R., Vollmuth, P., Subbiah, V., Bettegowda, C. & Pham, L. C. & 3 others, , Feb 2025, In: Nature reviews. Clinical oncology. 22, 2, p. 134-154 21 p.Research output: Contribution to journal › Review article › peer-review
-
Phase I study of adavosertib with radiation therapy and temozolomide in newly diagnosed glioblastoma and intratumoral drug levels in recurrent glioblastoma
Lee, E. Q., Alexander, B. M., Romo, C. G., Supko, J. G., Agar, N. Y. R., Talebi, Z., Ahluwalia, M. S., Desai, A. S., Dietrich, J., Kaley, T. J., Peereboom, D. M., Gantchev, J., Baquer, G., Santagata, S., Takebe, N., Desideri, S., Fisher, J. D., Sims, M., Ye, X. & Ligon, K. L. & 3 others, , Jan 17 2025, (E-pub ahead of print) In: Clinical cancer research : an official journal of the American Association for Cancer Research.Research output: Contribution to journal › Article › peer-review
-
State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs
Karim, N. A., Rabea, A. M., Mack, P. C., Subramanian, J., Khalil, E., Sherif, M., Marawan, R., Gaafar, T., Shash, L., Suzuki, K., Ahluwalia, M., Wahba, H., Aboelela, S., Al Ahmadi, A., Al Husaini, H., Mohsen, N., Khaled, R., Kassem, N., Khaled, H. & El Said, N. & 12 others, , Jan 2025, In: JTO clinical and research reports. 6, 1, p. 100776Research output: Contribution to journal › Article › peer-review
Activities
- 4 Membership of network
-
American Association for Cancer Research (External organization)
Ahluwalia, M. (Member)
2000 → …Activity: Membership › Membership of network
-
Society for Neuro-Oncology (External organization)
Ahluwalia, M. (Member)
2000 → …Activity: Membership › Membership of network
-
American College of Physicians (External organization)
Ahluwalia, M. (Member)
2000 → …Activity: Membership › Membership of network
-
American Society of Clinical Oncology (External organization)
Ahluwalia, M. (Member)
2000 → …Activity: Membership › Membership of network
Prizes
-
*Refer to CV for additional Honors & Awards*
Ahluwalia, M. (Recipient), 2024
Prize: Prize (including medals and awards)
-
American Society of Clinical Oncology Leadership Development Program Award (2015-16)
Ahluwalia, M. (Recipient), 2015
Prize: Prize (including medals and awards)
-
American Society of Clinical Oncology Taxonomy Task Force Member (2016)
Ahluwalia, M. (Recipient), 2016
Prize: Prize (including medals and awards)
-
Crains Forty Under 40, Northeast Ohio (2017)
Ahluwalia, M. (Recipient), 2017
Prize: Prize (including medals and awards)
-
Dean and Diane Miller Family Endowed Chair in Neuro-Oncology (2015-2019)
Ahluwalia, M. (Recipient), 2015
Prize: Prize (including medals and awards)